- Home
- PAYS vs ALEC Comparison
PAYS vs ALEC Comparison
Compare PAYS & ALEC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | PAYS | ALEC |
|---|---|---|
| Founded | 2001 | 2013 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Business Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 293.4M | 268.2M |
| IPO Year | 2020 | 2019 |
Fundamental Metrics
Financial Performance| Metric | PAYS | ALEC |
|---|---|---|
| Price | $6.52 | $2.31 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 3 | 6 |
| Target Price | ★ $9.42 | $4.83 |
| AVG Volume (30 Days) | ★ 802.5K | 630.7K |
| Earning Date | 05-12-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 85.71 | N/A |
| EPS | ★ 0.13 | N/A |
| Revenue | ★ $24,120,434.00 | $21,045,000.00 |
| Revenue This Year | $33.83 | $2.03 |
| Revenue Next Year | $14.89 | $29.87 |
| P/E Ratio | $50.65 | ★ N/A |
| Revenue Growth | ★ N/A | N/A |
| 52 Week Low | $2.28 | $0.98 |
| 52 Week High | $8.88 | $3.40 |
Technical Indicators
Market Signals| Indicator | PAYS | ALEC |
|---|---|---|
| Relative Strength Index (RSI) | 69.26 | 47.19 |
| Support Level | $5.09 | $2.30 |
| Resistance Level | $8.88 | $2.57 |
| Average True Range (ATR) | 0.35 | 0.16 |
| MACD | -0.01 | -0.03 |
| Stochastic Oscillator | 94.04 | 8.53 |
Price Performance
Historical ComparisonAbout PAYS Paysign Inc.
PaySign Inc is a provider of prepaid card programs, comprehensive patient affordability offerings, digital banking services, and integrated payment processing designed for businesses, consumers, and government institutions. The Company creates customized payment solutions for clients across industries, including pharmaceutical, healthcare, hospitality, and retail. The company's revenues include fees generated from cardholder fees, interchange, card program management fees, transaction claims processing fees, and settlement income.
About ALEC Alector Inc.
Alector Inc is a clinical-stage biotechnology company focused on developing therapies for neurodegenerative diseases. The company advances a pipeline of product candidates including Nivisnebart (AL101/GSK4527226) for Alzheimer's disease, AL137 for Alzheimer's disease, AL050 for Parkinson's disease and Lewy body dementia, and AL064, an siRNA program targeting tau for Alzheimer's disease and other tauopathies, supported by its proprietary Alector Brain Carrier (ABC) platform designed to improve delivery of therapeutics across the blood-brain barrier.